Jurisprudence récente: la Cour fédérale n’invalide pas le brevet de Pfizer pour le Viagra

Pfizer Canada Inc. v. Novopharm Limited., 2009 FC 638, (June 18, 2009)

http://decisions.fct-cf.gc.ca/en/2009/2009fc638/2009fc638.html

Questions en litige:

ISSUE NO. 1:    Whether the invention of sildenafil for the treatment of ED was obvious at the time of the priority date 

ISSUE NO. 2: Whether the ‘446 Patent meets the utility requirement by demonstrating or soundly predicting the utility of sildenafil by the Canadian filing date 

ISSUE NO. 3:  Whether the disclosure in the ‘446 Patent met the statutory requirement for disclosure set out in s. 27(3) of the Patent Act as of the ‘446 Patent’s publication date

 

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: